Duration of colonization and determinants of earlier clearance of colonization with methicillin-resistant staphylococcus aureus

Clinical Infectious Diseases

Volumn 60, Issue 10, 2015, Pages 1489-1496

  Cluzet, Valerie C ^a   Gerber, Jeffrey S ^b,c   Nachamkin, Irving ^b   Metlay, Joshua P ⁱ   Zaoutis, Theoklis E ^b,c   Davis, Meghan F ^j   Julian, Kathleen G ^g   Royer, David ^h   Linkin, Darren R ^a,d   Coffin, Susan E ^b,c   Margolis, David J ^b   Hollander, Judd E ^f   Mistry, Rakesh D ^k   Gavin, Laurence J ^e   Tolomeo, Pam ^b   Wise, Jacqueleen A ^b   Wheeler, Mary K ^b   Bilker, Warren B ^b   Han, Xiaoyan ^b   Hu, Baofeng ^b   Fishman, Neil O ^a   Lautenbach, Ebbing ^a,b   more..

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e PENN PRESBYTERIAN MEDICAL CENTER   (United States)

^f THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^g PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^h LINCOLN UNIVERSITY   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^k CHILDREN S HOSPITAL COLORADO   (United States)

more..

Author keywords

methicillin resistant Staphylococcus aureus (MRSA); MRSA colonization; MRSA decolonization; MRSA skin and soft tissue infection

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFALEXIN; CHLORHEXIDINE; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; LEVOFLOXACIN; PSEUDOMONIC ACID; ANTIINFECTIVE AGENT;

ADULT; AGE; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CAUCASIAN; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; INCUBATION TIME; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MULTICENTER STUDY; NEOPLASM; PRESCRIPTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RACE DIFFERENCE; SOFT TISSUE INFECTION; STAPHYLOCOCCAL SKIN INFECTION; ADOLESCENT; CHILD; COMMUNITY-ACQUIRED INFECTIONS; HETEROZYGOTE; ISOLATION AND PURIFICATION; LONGITUDINAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; PRESCHOOL CHILD; PREVALENCE; STAPHYLOCOCCAL INFECTIONS; TIME FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CARRIER STATE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PREVALENCE; PROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; TIME FACTORS; YOUNG ADULT;

EID: 84929190247     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ075     Document Type: Article

References (36)

1. Pfaller MA, Jones RN, Doern GV, Kugler K. Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother 1998; 42:1762-70.
2. Zetola N, Francis JS, Nuermberger EL, Bishai WR. Community-Acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005; 5:275-86.
3. Salgado CD, Farr BM, Calfee DP. Community-Acquired methicillin-resistant Staphylococcus aureus: a meta-Analysis of prevalence and risk factors. Clin Infect Dis 2003; 36:131-9.
4. Fritz SA, Hogan PG, Hayek G, et al. Staphylococcus aureus colonization in children with community-Associated Staphylococcus aureus skin infections and their household contacts. Arch Pediatr Adolesc Med 2012; 166:551-7.
5. Mollema FP, Richardus JH, Behrendt M, et al. Transmission of methicillin-resistant Staphylococcus aureus to household contacts. J Clin Microbiol 2010; 48:202-7.
6. Wang YC, Coxson P, Shen YM, Goldman L, Bibbins-Domingo K. A penny-per-ounce tax on sugar-sweetened beverages would cut health and cost burdens of diabetes. Health Aff 2012; 31:199-207.
7. Calfee DP, Durbin LJ, Germanson TP, Toney DM, Smith EB, Farr BM. Spread of methicillin-resistant Staphylococcus aureus (MRSA) among household contacts of individuals with nosocomially acquired MRSA. Infect Control Hosp Epidemiol 2003; 24:422-6.
8. Moran GJ, Amii RN, Abrahamian FM, Talan DA. Methicillin-resistant Staphylococcus aureus in community-Acquired skin infections. Emerg Infect Dis 2005; 11:928-30.
9. Lucet JC, Paoletti X, Demontpion C, et al. Carriage ofmethicillin-resistant Staphylococcus aureus in home care settings: prevalence, duration, and transmission to household members. Arch InternMed 2009; 169:1372-8.
10. Larsson AK, Gustafsson E, Nilsson AC, Odenholt I, Ringberg H, Melander E. Duration of methicillin-resistant Staphylococcus aureus colonization after diagnosis: a four-year experience from southern Sweden. Scand J Infect Dis 2011; 43:456-62.
11. Lautenbach E, Nachamkin I, Hu B, et al. Surveillance cultures for detection of methicillin-resistant Staphylococcus aureus: diagnostic yield of anatomic sites and comparison of provider-And patient-collected samples. Infect Control Hosp Epidemiol 2009; 30:380-2.
12. Mermel LA, Cartony JM, Covington P, Maxey G, Morse D. Methicillinresistant Staphylococcus aureus colonization at different body sites: a prospective, quantitative analysis. J Clin Microbiol 2011; 49:1119-21.
13. Eveillard M, de Lassence A, Lancien E, Barnaud G, Ricard JD, Joly-Guillou ML. Evaluation of a strategy of screening multiple anatomical sites for methicillin-resistant Staphylococcus aureus at admission to a teaching hospital. Infect Control Hosp Epidemiol 2006; 27:181-4.
14. Ringberg H, Petersson AC, Walder M, Hugo Johansson PJ. The throat: an important site for MRSA colonization. Scand J Infect Dis 2006; 38:888-93.
15. Boyce JM, Havill NL, Maria B. Frequency and possible infection control implications of gastrointestinal colonization with methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2005; 43:5992-5.
16. Han Z, Lautenbach E, Fishman NO, Nachamkin I. Evaluation of mannitol salt agar, CHROMaga Staph aureus and CHROMaga MRSA for detection of methicillin-resistant Staphylococcus aureus from nasal swab specimens. J Med Microbiol 2007; 56:43-6.
17. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: eighteenth informational supplement. M100-S18. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
18. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 2001; 344:11-6.
19. Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol 1993; 138:923-36.
20. Robicsek A, Beaumont JL, Peterson LR. Duration of colonization with methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2009; 48:910-3.
21. Scanvic A, Denic L, Gaillon S, Giry P, Andremont A, Lucet JC. Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage. Clin Infect Dis 2001; 32:1393-8.
22. Eveillard M, Martin Y, Hidri N, Boussougant Y, Joly-Guillou ML. Carriage of methicillin-resistant Staphylococcus aureus among hospital employees: prevalence, duration, and transmission to households. Infect Control Hosp Epidemiol 2004; 25:114-20.
23. Sanford MD, Widmer AF, Bale MJ, Jones RN, Wenzel RP. Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1994; 19:1123-8.
24. Tzermpos F, Kanni T, Tzanetakou V, et al. An algorithm for the management of Staphylococcus aureus carriage within patients with recurrent staphylococcal skin infections. J Infect Chemother 2013; 19:806-11.
25. Ammerlaan HS, Kluytmans JA, Berkhout H, et al. Eradication of carriage with methicillin-resistant Staphylococcus aureus: effectiveness of a national guideline. J Antimicrob Chemother 2011; 66:2409-17.
26. Simor AE, Phillips E, McGeer A, et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis 2007; 44:178-85.
27. Frei CR, Miller ML, Lewis JS II, et al. Trimethoprim-sulfamethoxazole or clindamycin for community-Associated MRSA (CA-MRSA) skin infections. J Am Board Fam Med 2010; 23:714-9.
28. Williams VR, Callery S, Vearncombe M, Simor AE. The role of colonization pressure in nosocomial transmission of methicillin-resistant Staphylococcus aureus. Am J Infect Control 2009; 37:106-10.
29. Popoola VO, Carroll KC, Ross T, Reich NG, Perl TM, Milstone AM. Impact of colonization pressure and strain type on methicillin-resistant Staphylococcus aureus transmission in children. Clin Infect Dis 2013; 57:1458-60.
30. Rodriguez M, Hogan PG, Krauss M, Warren DK, Fritz SA. Measurement and impact of colonization pressure in households. J Pediatr Infect Dis Soc 2013; 2:147-54.
31. Davis KA, Stewart JJ, Crouch HK, Florez CE, Hospenthal DR. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis 2004; 39:776-82.
32. Marschall J, Muhlemann K. Duration of methicillin-resistant Staphylococcus aureus carriage, according to risk factors for acquisition. Infect Control Hosp Epidemiol 2006; 27:1206-12.
33. Ellis MW, Hospenthal DR, Dooley DP, Gray PJ, Murray CK. Natural history of community-Acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis 2004; 39:971-9.
34. Fritz SA, Hogan PG, Hayek G, et al. Household versus individual approaches to eradication of community-Associated Staphylococcus aureus in children: a randomized trial. Clin Infect Dis 2012; 54:743-51.
35. Pujol M, Peña C, Pallares R, et al. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med 1996; 100:509-16.
36. Garrouste-Orgeas M, Timsit JF, Kallel H, et al. Colonization with methicillin-resistant Staphylococcus aureus in ICU patients: morbidity, mortality, and glycopeptide use. Infect Control Hosp Epidemiol 2001; 22:687-92.